旧金山大学的一项研究发现,在撒哈拉以南非洲,5岁及以下的儿童中,阿齐思罗米辛可以使儿童死亡率降低14%. UC San Francisco study finds azithromycin in Sub-Saharan Africa children aged 5 and under could reduce child mortality by 14%.
旧金山大学的一项研究表明, 在撒哈拉以南非洲地区, 用常见的抗生素阿兹胺治疗5岁及以下的儿童, 可以使儿童死亡率降低14%. A UC San Francisco study suggests that treating children aged 5 and under in Sub-Saharan Africa with azithromycin, a common antibiotic, could reduce child mortality by 14%. 卫生组织先前的建议仅包括因抗生素抗药性问题而不满1至11个月的婴儿。 The previous WHO recommendation only included infants between 1-11 months old due to antibiotic resistance concerns. 研究发现,治疗年长儿童有利于较年幼、较易受伤害的儿童,因为年长的兄弟姐妹帮助感染。 The study found that treating older children benefits the younger, more vulnerable ones, as older siblings help transmit infections. 调查结果公布在《新英格兰医学杂志》上。 The findings were published in the New England Journal of Medicine.